M6A alpha Base transferase METTL3 enhances osteosarcoma progression by increasing m6A methylation of LEF1 mRNA, thereby activating the Wnt/β-catenin signaling pathway and promoting cancer cell proliferation, migration, and invasion (54). Here, METTL3 is linked to osteosarcoma.